Genpact (NYSE: G), a global professional services firm, saw its shares plummet 7.39% in pre-market trading on Thursday, despite reporting better-than-expected first-quarter earnings. The sharp decline comes as JP Morgan cut its target price for the company, raising concerns among investors.
Genpact reported adjusted earnings of 84 cents per share for the quarter ended March 31, 2025, surpassing analysts' expectations of 79 cents per share. The company's revenue rose 7.4% to $1.21 billion, meeting Wall Street's projections. Additionally, Genpact posted a quarterly net income of $130.85 million, demonstrating solid financial performance.
However, the positive earnings report was overshadowed by JP Morgan's decision to lower its target price for Genpact from $55 to $49. This significant reduction in price target appears to have spooked investors, leading to the substantial pre-market sell-off. The disconnect between the company's strong financial results and the stock's negative performance suggests that market participants may be concerned about Genpact's future growth prospects or potential headwinds in the business support services sector.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。